BioXell logo — Pioneering Innovation in Biomedical Research Since 2002

BioXell

Pioneering Innovation in Biomedical Research Since 2002

Founded 2002 Series C Total: $72.50M Biotechnology, Education

General Information

Company Name BioXell
Founded Year 2002
Founders / Decision Makers
Team member
Industries Biotechnology, Education
Funding Stage Series C
Social

Get notified when BioXell moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioXell

BioXell is a biotechnology startup with a focus on chronic inflammatory disease and autoimmunity, established in 2002. The company emerged from Roche Milano Ricerche, a renowned biomedical research institute founded in the 1990s. Dr. Francesco Sinigaglia, the former CEO and founder, leveraged his extensive scientific background to conceptualize BioXell, with funding of $22 million from MPM Capital, Index Ventures, and Life Science Partners. The company's latest investment of €10.50M came during the Series C round on 15th March 2006, with notable investors including Index Ventures, TVM Capital, BB Biotech Ventures, and MVM Life Science Partners. BioXell operates in the biotechnology and education sectors, striving to pioneer innovation in biomedical research.

Taxonomy: Biomedical Research, Chronic Inflammatory Disease, Autoimmunity, Research Institute, Milan-based, Scientific Career, Spinout, Investment, MPM Capital, Index Ventures, Life Science Partners, Francesco Sinigaglia, Roche Milano Ricerche, Innovation, Start-up

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 4
Investor Investor Investor
•••• ••••
15 Mar 2006
Series C •••••• 6
Investor Investor Investor Investor Investor
•••• ••••
20 Oct 2004
Series B •••••• - 21 May 2003
Series A •••••• - 04 Jan 2002

BioXell Alternatives & Competitors

BioXell vs

A world-leading institute in global health.

701 employees
Education, Health Care
BioXell vs

Researchers and Clinicians united to restore vision.

102 employees
Biotechnology, Education
BioXell vs

Electron Diffraction Analysis of Chemical and Pharmaceutical Compounds, Beyond Traditional Complemen...

Unknown
18 employees

FAQ About BioXell

Pioneering Innovation in Biomedical Research Since 2002
BioXell was founded in 2002.
BioXell operates in the following industries: Biotechnology, Education.
BioXell has completed 4 funding rounds, raising a total of $72.50M. The latest funding stage is Series C.
Top alternatives and competitors to BioXell include Swiss Tropical and Public Health Institute, Institute of Molecular and Clinical Ophthalmology Basel (IOB), ELDICO Scientific AG, NUTRILOG, Basel Institute on Governance. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioXell and Swiss Tropical and Public Health Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioXell and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy